A Comprehensive Review of Sarcoidosis: From Clinical Manifestations to Management Strategies
DOI:
https://doi.org/10.12775/JEHS.2024.75.56452Keywords
sarcoidosis, neurosarcoidosis, pulmonary fibrosis, cardiac sarcoidosis, Löfgren syndromeAbstract
Introduction and purpose: Sarcoidosis is a complex, multi – system disease characterized by the formation of non – caseating granulomas that can affect nearly every organ in the body, though lungs and lymph nodes are the most commonly involved. The disease's clinical presentation is highly variable, ranging from asymptomatic cases to severe, organ-threatening manifestations, with significant implications for diagnosis and treatment. The aim of this study is to present current state of knowledge on clinical features, etiology, diagnosis and treatment methods of sarcoidosis.
Materials and methods: The review is based on the analysis of literature available on Pubmed, Google Scholar and UpToDate databases. To search for relevant scientific content the following keywords were used: sarcoidosis, symptoms, etiology, diagnosis, treatment, neurosarcoidosis, cutaneous sarcoidosis, cardiac sarcoidosis, Löfgren syndrome.
Conclusions: Despite numerous studies, the cause of sarcoidosis still remains unknown, which leaves a field for researchers for further investigation. Diagnosis of sarcoidosis is challenging, it typically involves histological confirmation through biopsy, supported by imaging studies, laboratory tests and need to exclude other causes. Treatment is limited, focused on alleviating the symptoms and preventing organ failure, therefore further research into more effective or targeted therapies is advisable.
References
Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, diagnosis, clinical features, and treatments. J Clin Med. 2020;9(4). https://doi.org/10.3390/jcm9041081
Crouser ED, Maier LA, Baughman RP, et al. Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):E26-E51. https://doi.org/10.1164/RCCM.202002-0251ST
Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and Its Management. New England Journal of Medicine. 2021;385(11):1018-1032. https://doi.org/10.1056/nejmra2101555
Shah HH, Zehra SA, Shahrukh A, et al. Cardiac sarcoidosis: a comprehensive review of risk factors, pathogenesis, diagnosis, clinical manifestations, and treatment strategies. Front Cardiovasc Med. 2023;10. https://doi.org/10.3389/fcvm.2023.1156474
Arkema E V., Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis. 2018;9(11):227-240. https://doi.org/10.1177/2040622318790197
Bogdan M, NitschOsuch A, Kanecki K, et al. Sarcoidosis among hospitalized patients in Poland: A study based on a national hospital registry. Pol Arch Intern Med. 2019;129(9):580-585. https://doi.org/10.20452/pamw.14927
Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. European Respiratory Journal. 2008;31(2):372-379. https://doi.org/10.1183/09031936.00075307
Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl. 2001;32:56s-68s. http://www.ncbi.nlm.nih.gov/pubmed/11816825
Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324-1330. https://doi.org/10.1164/rccm.200402-249OC
Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest. 1999;116(5):1183-1193. https://doi.org/10.1378/chest.116.5.1183
Dumas O, Boggs KM, Cozier YC, Stampfer MJ, Camargo CA. Prospective study of body mass index and risk of sarcoidosis in US women. European Respiratory Journal. 2017;50(4):1701397. https://doi.org/10.1183/13993003.01397-2017
Dehara M, Sachs MC, Arkema E V., Grunewald J, Blomberg A. Modifiable lifestyle risk factors for sarcoidosis: a nested case–control study. ERJ Open Res. 2023;9(2). https://doi.org/10.1183/23120541.00492-2022
Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: Implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007;37(6):748-755. https://doi.org/10.1165/rcmb.2007-0025OC
Rossides M, Grunewald J, Eklund A, et al. Familial aggregation and heritability of sarcoidosis: A Swedish nested case-control study. European Respiratory Journal. 2018;52(2). https://doi.org/10.1183/13993003.00385-2018
Starshinova AA, Malkova AM, Basantsova NY, et al. Sarcoidosis as an Autoimmune Disease. Front Immunol. 2020;10. https://doi.org/10.3389/fimmu.2019.02933
Mañá J, Rubio-Rivas M, Villalba N, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis. Medicine (United States). 2017;96(29). https://doi.org/10.1097/MD.0000000000007595
Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. European Respiratory Journal. 2021;58(6). https://doi.org/10.1183/13993003.04079-2020
Sève P, Pacheco Y, Durupt F, et al. Sarcoidosis: A clinical overview from symptoms to diagnosis. Cells. 2021;10(4). https://doi.org/10.3390/cells10040766
S.F. da Silva I, Costa Silva R, Sopa I, Peixoto L. Clinical Manifestations of Sarcoidosis. In: Sarcoidosis - Diagnosis, Research, and Therapy of a Granulomatous Disease of Unknown Etiology [Working Title]. IntechOpen; 2023. https://doi.org/10.5772/intechopen.1002282
Sanchez M, Haimovic A, Prystowsky S. Sarcoidosis. Dermatol Clin. 2015;33(3):389-416. https://doi.org/10.1016/j.det.2015.03.006
Denny MC, Fotino AD. The Heerfordt-Waldenström Syndrome as an Initial Presentation of Sarcoidosis. Baylor University Medical Center Proceedings. 2013;26(4):390-392. https://doi.org/10.1080/08998280.2013.11929014
Criado E, Sánchez M, Ramírez J, et al. Pulmonary sarcoidosis: Typical and atypical manifestations at high- resolution CT with pathologic correlation. Radiographics. 2010;30(6):1567-1586. https://doi.org/10.1148/rg.306105512
Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389-402. https://doi.org/10.1016/S2213-2600(18)30064-X
Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with Pulmonary Fibrosis. American Journal of Roentgenology. 2000;174(6):1751-1757. https://doi.org/10.2214/ajr.174.6.1741751
Judson MA, Thompson BW, Rabin DL, et al. The diagnostic pathway to sarcoidosis. Chest. 2003;123(2):406-412. https://doi.org/10.1378/chest.123.2.406
Ungprasert P, Ryu JH, Matteson EL. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358-375. https://doi.org/10.1016/j.mayocpiqo.2019.04.006
Marcoval J, Mañá J, Rubio M. Specific cutaneous lesions in patients with systemic sarcoidosis: Relationship to severity and chronicity of disease. Clin Exp Dermatol. 2011;36(7):739-744. https://doi.org/10.1111/j.1365-2230.2011.04128.x
Wei CH, Huang YH, Shih YC, Tseng FW, Yang CH. Sarcoidosis with cutaneous granulomatous vasculitis. Australasian Journal of Dermatology. 2010;51(3):198-201. https://doi.org/10.1111/j.1440-0960.2010.00630.x
Schupp JC, Freitag-Wolf S, Bargagli E, et al. Phenotypes of organ involvement in sarcoidosis. European Respiratory Journal. 2018;51(1). doi:10.1183/13993003.00991-2017
Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):452-462. https://doi.org/10.1055/s-0030-1262213
Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015;36(4):669-683. https://doi.org/10.1016/j.ccm.2015.08.009
Takase H. Characteristics and management of ocular sarcoidosis. Immunol Med. 2022;45(1):12-21. https://doi.org/10.1080/25785826.2021.1940740
Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. Am J Med. 1977;63(1):86-108. https://doi.org/10.1016/0002-9343(77)90121-8
Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. New England Journal of Medicine. 2007;357(21):2153-2165. https://doi.org/10.1056/NEJMra071714
Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. American Journal of Gastroenterology. 2008;103(12):3184-3192. https://doi.org/10.1111/j.1572-0241.2008.02202.x
Hena KM. Sarcoidosis Epidemiology: Race Matters. Front Immunol. 2020;11. https://doi.org/10.3389/fimmu.2020.537382
Gezer NS, Başara I, Altay C, et al. Abdominal sarcoidosis: Cross-sectional imaging findings. Diagnostic and Interventional Radiology. 2015;21(2):111-117. https://doi.org/10.5152/dir.2014.14210
Kidd DP. Neurosarcoidosis: Clinical manifestations, investigation and treatment. Pract Neurol. 2020;20(3):199-212. https://doi.org/10.1136/practneurol-2019-002349
Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment. Neurology(R) neuroimmunology & neuroinflammation. 2021;8(6). https://doi.org/10.1212/NXI.0000000000001084
Joubert B, Chapelon-Abric C, Biard L, et al. Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis. JAMA Neurol. 2017;74(11):1336-1344. https://doi.org/10.1001/jamaneurol.2017.2492
Rossides M, Darlington P, Kullberg S, Arkema E V. Sarcoidosis: Epidemiology and clinical insights. J Intern Med. 2023;293(6):668-680. doi:10.1111/joim.13629
von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis. JAMA. 2013;309(23):2457. https://doi.org/10.1001/jama.2013.5823
Ibitoye RT, Wilkins A, Scolding NJ. Neurosarcoidosis: a clinical approach to diagnosis and management. J Neurol. 2017;264(5):1023-1028. https://doi.org/10.1007/s00415-016-8336-4
Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung. 2016;194(1):91-95. https://doi.org/10.1007/s00408-015-9826-3
Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JMM, van Velzen-Blad H. Serum Soluble Interleukin-2 Receptor Measurement in Patients With Sarcoidosis. Chest. 2003;124(1):186-195. https://doi.org/10.1378/chest.124.1.186
Wijsenbeek MS, Culver DA. Treatment of Sarcoidosis. Clin Chest Med. 2015;36(4):751-767. doi:10.1016/j.ccm.2015.08.015
Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol. 2020;11. https://doi.org/10.3389/fimmu.2020.545413
Obi ON, Saketkoo LA, Russell AM, Baughman RP. Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches. Front Med (Lausanne). 2022;9. https://doi.org/10.3389/fmed.2022.991783
Baughman RP, Lower EE. Treatment of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):79-92. https://doi.org/10.1007/s12016-015-8492-9
James WE, Baughman R. Treatment of sarcoidosis: grading the evidence. Expert Rev Clin Pharmacol. 2018;11(7):677-687. https://doi.org/10.1080/17512433.2018.1486706
Kampstra NA, Van Der Nat PB, Dijksman LM, et al. Results of the standard set for pulmonary sarcoidosis: Feasibility and multicentre outcomes. ERJ Open Res. 2019;5(4). https://doi.org/10.1183/23120541.00094-2019
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Olga Śpiołek, Jan Siwiec, Aleksandra Słowikowska, Mateusz Teofilak, Julia Szatkowska, Natalia Smyl, Marcelina Sztyler-Krąkowska, Agnieszka Wąsowicz, Franciszek Kędziora, Dariusz Fabian
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 54
Number of citations: 0